Experts discovered in olive oil a potent inhibitor for
multiple myeloma.
Multiple myeloma (MM) is a plasma cell malignancy that
causes devastating bone destruction by activating osteoclasts in the bone
marrow milieu. MM is the second of all hematological malignancies. Thus, the
search for new pharmacological weapons is under intensive investigation being
MM a critically important public health goal.
Recently, it has been demonstrated that macrophage inflammatory protein 1- alpha (MIP-1α) is crucially involved in the development of osteolytic bone lesions in MM. Phenolic components of extra virgin olive oil are reported to have anti tumor activity. However, the underlying mechanisms and specific targets of extra virgin olive oil remain to be elucidated.
In this study, are investigated the effects of a
recently isolated novel extra virgin olive oil polyphenol, oleocanthal, on the
human multiple myeloma cell line ARH-77. This natural compound, responsible for
the pungency of some of these oils, has a remarkable in vitro activity by
inhibiting MIP-1α expression and secretion in MM cells. In addition, is also demonstrated
that oleocanthal inhibits MM cells proliferation by inducing the activation of
apoptosis mechanisms and by down-regulating ERK1/2 and AKT signal transduction
pathways.
"Oleocanthal inhibits
proliferation and MIP-1α expression in human multiple myeloma cells."
Scotece M, Gómez R, Conde
J, Lopez V, Gómez-Reino JJ,
Lago F, Smith AB, Gualillo O. Santiago University Clinical Hospital, NEIRID
Lab, NeuroEndocrine Interactions in Rheumatology and Inflammatory Diseases,
Research Area, Laboratory nº 9 Building C, Level -2 Trav. Choupana sn,
15706 Santiago de Compostela, Spain.